Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118171) titled 'A prospective, observational, multicenter, cohort trial to evaluate the association between immune checkpoint inhibitors and coronary atherosclerosis in patients with malignant tumors complicated with coronary atherosclerotic heart disease' on Feb. 3.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
Malignant tumor
Coronary atherosclerotic heart disease
Intervention:
Exposed group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-03
Target Sample Size: Exposed group:60;Non-exposed group:60; ...